▶ 調査レポート

薬物アレルギー治療/治療薬の世界市場(~2026年)

• 英文タイトル:Global Drug Allergy Treatments and Drugs Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。薬物アレルギー治療/治療薬の世界市場(~2026年) / Global Drug Allergy Treatments and Drugs Market Insights and Forecast to 2026 / MRC2-11QY05438資料のイメージです。• レポートコード:MRC2-11QY05438
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は薬物アレルギー治療/治療薬のグローバル市場について調査・分析したレポートです。種類別(ペニシリン・関連薬、サルファ剤、インスリン、ヨウ素、化学療法薬、その他)市場規模、用途別(病院、診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別薬物アレルギー治療/治療薬の競争状況、市場シェア
・世界の薬物アレルギー治療/治療薬市場:種類別市場規模 2015年-2020年(ペニシリン・関連薬、サルファ剤、インスリン、ヨウ素、化学療法薬、その他)
・世界の薬物アレルギー治療/治療薬市場:種類別市場規模予測 2021年-2026年(ペニシリン・関連薬、サルファ剤、インスリン、ヨウ素、化学療法薬、その他)
・世界の薬物アレルギー治療/治療薬市場:用途別市場規模 2015年-2020年(病院、診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業)
・世界の薬物アレルギー治療/治療薬市場:用途別市場規模予測 2021年-2026年(病院、診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業)
・北米の薬物アレルギー治療/治療薬市場分析:米国、カナダ
・ヨーロッパの薬物アレルギー治療/治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの薬物アレルギー治療/治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の薬物アレルギー治療/治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの薬物アレルギー治療/治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Stallergenes Greer、Allergy Therapeutics、HAL Allergy Group、Circassia、GlaxoSmithKline plc、Sunovion Pharmaceuticals、Teva Pharmaceutical Industries、Allergan plc、Mayo Clinic、AAFA
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Drug Allergy Treatments and Drugs Market
The global Drug Allergy Treatments and Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Drug Allergy Treatments and Drugs Scope and Market Size
Drug Allergy Treatments and Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Allergy Treatments and Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Drug Allergy Treatments and Drugs market is segmented into
Penicillin and Related Drugs
Sulfa Drugs
Insulin
Iodine
Chemotherapy Drugs
Other

Segment by Application, the Drug Allergy Treatments and Drugs market is segmented into
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies

Regional and Country-level Analysis
The Drug Allergy Treatments and Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug Allergy Treatments and Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Drug Allergy Treatments and Drugs Market Share Analysis
Drug Allergy Treatments and Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drug Allergy Treatments and Drugs business, the date to enter into the Drug Allergy Treatments and Drugs market, Drug Allergy Treatments and Drugs product introduction, recent developments, etc.

The major vendors covered:
Stallergenes Greer
Allergy Therapeutics
HAL Allergy Group
Circassia
GlaxoSmithKline plc
Sunovion Pharmaceuticals
Teva Pharmaceutical Industries
Allergan plc
Mayo Clinic
AAFA

レポート目次

1 Study Coverage
1.1 Drug Allergy Treatments and Drugs Product Introduction
1.2 Market Segments
1.3 Key Drug Allergy Treatments and Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Drug Allergy Treatments and Drugs Market Size Growth Rate by Type
1.4.2 Penicillin and Related Drugs
1.4.3 Sulfa Drugs
1.4.4 Insulin
1.4.5 Iodine
1.4.6 Chemotherapy Drugs
1.4.7 Other
1.5 Market by Application
1.5.1 Global Drug Allergy Treatments and Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Diagnostic Laboratories
1.5.4 Research & Academic Laboratories
1.5.5 Pharmaceutical & Biotechnology Companies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drug Allergy Treatments and Drugs Market Size, Estimates and Forecasts
2.1.1 Global Drug Allergy Treatments and Drugs Revenue 2015-2026
2.1.2 Global Drug Allergy Treatments and Drugs Sales 2015-2026
2.2 Global Drug Allergy Treatments and Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Drug Allergy Treatments and Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Drug Allergy Treatments and Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Drug Allergy Treatments and Drugs Competitor Landscape by Players
3.1 Drug Allergy Treatments and Drugs Sales by Manufacturers
3.1.1 Drug Allergy Treatments and Drugs Sales by Manufacturers (2015-2020)
3.1.2 Drug Allergy Treatments and Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Drug Allergy Treatments and Drugs Revenue by Manufacturers
3.2.1 Drug Allergy Treatments and Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Drug Allergy Treatments and Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drug Allergy Treatments and Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Drug Allergy Treatments and Drugs Revenue in 2019
3.2.5 Global Drug Allergy Treatments and Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Drug Allergy Treatments and Drugs Price by Manufacturers
3.4 Drug Allergy Treatments and Drugs Manufacturing Base Distribution, Product Types
3.4.1 Drug Allergy Treatments and Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug Allergy Treatments and Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Drug Allergy Treatments and Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Drug Allergy Treatments and Drugs Market Size by Type (2015-2020)
4.1.1 Global Drug Allergy Treatments and Drugs Sales by Type (2015-2020)
4.1.2 Global Drug Allergy Treatments and Drugs Revenue by Type (2015-2020)
4.1.3 Drug Allergy Treatments and Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Drug Allergy Treatments and Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Drug Allergy Treatments and Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Drug Allergy Treatments and Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Drug Allergy Treatments and Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Drug Allergy Treatments and Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Drug Allergy Treatments and Drugs Market Size by Application (2015-2020)
5.1.1 Global Drug Allergy Treatments and Drugs Sales by Application (2015-2020)
5.1.2 Global Drug Allergy Treatments and Drugs Revenue by Application (2015-2020)
5.1.3 Drug Allergy Treatments and Drugs Price by Application (2015-2020)
5.2 Drug Allergy Treatments and Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Drug Allergy Treatments and Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Drug Allergy Treatments and Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Drug Allergy Treatments and Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Drug Allergy Treatments and Drugs by Country
6.1.1 North America Drug Allergy Treatments and Drugs Sales by Country
6.1.2 North America Drug Allergy Treatments and Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Drug Allergy Treatments and Drugs Market Facts & Figures by Type
6.3 North America Drug Allergy Treatments and Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Drug Allergy Treatments and Drugs by Country
7.1.1 Europe Drug Allergy Treatments and Drugs Sales by Country
7.1.2 Europe Drug Allergy Treatments and Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drug Allergy Treatments and Drugs Market Facts & Figures by Type
7.3 Europe Drug Allergy Treatments and Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Drug Allergy Treatments and Drugs by Region
8.1.1 Asia Pacific Drug Allergy Treatments and Drugs Sales by Region
8.1.2 Asia Pacific Drug Allergy Treatments and Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Drug Allergy Treatments and Drugs Market Facts & Figures by Type
8.3 Asia Pacific Drug Allergy Treatments and Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Drug Allergy Treatments and Drugs by Country
9.1.1 Latin America Drug Allergy Treatments and Drugs Sales by Country
9.1.2 Latin America Drug Allergy Treatments and Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Drug Allergy Treatments and Drugs Market Facts & Figures by Type
9.3 Central & South America Drug Allergy Treatments and Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Drug Allergy Treatments and Drugs by Country
10.1.1 Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country
10.1.2 Middle East and Africa Drug Allergy Treatments and Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Drug Allergy Treatments and Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Drug Allergy Treatments and Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Stallergenes Greer
11.1.1 Stallergenes Greer Corporation Information
11.1.2 Stallergenes Greer Description and Business Overview
11.1.3 Stallergenes Greer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Stallergenes Greer Drug Allergy Treatments and Drugs Products Offered
11.1.5 Stallergenes Greer Related Developments
11.2 Allergy Therapeutics
11.2.1 Allergy Therapeutics Corporation Information
11.2.2 Allergy Therapeutics Description and Business Overview
11.2.3 Allergy Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergy Therapeutics Drug Allergy Treatments and Drugs Products Offered
11.2.5 Allergy Therapeutics Related Developments
11.3 HAL Allergy Group
11.3.1 HAL Allergy Group Corporation Information
11.3.2 HAL Allergy Group Description and Business Overview
11.3.3 HAL Allergy Group Sales, Revenue and Gross Margin (2015-2020)
11.3.4 HAL Allergy Group Drug Allergy Treatments and Drugs Products Offered
11.3.5 HAL Allergy Group Related Developments
11.4 Circassia
11.4.1 Circassia Corporation Information
11.4.2 Circassia Description and Business Overview
11.4.3 Circassia Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Circassia Drug Allergy Treatments and Drugs Products Offered
11.4.5 Circassia Related Developments
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Corporation Information
11.5.2 GlaxoSmithKline plc Description and Business Overview
11.5.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Products Offered
11.5.5 GlaxoSmithKline plc Related Developments
11.6 Sunovion Pharmaceuticals
11.6.1 Sunovion Pharmaceuticals Corporation Information
11.6.2 Sunovion Pharmaceuticals Description and Business Overview
11.6.3 Sunovion Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Products Offered
11.6.5 Sunovion Pharmaceuticals Related Developments
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Corporation Information
11.7.2 Teva Pharmaceutical Industries Description and Business Overview
11.7.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Products Offered
11.7.5 Teva Pharmaceutical Industries Related Developments
11.8 Allergan plc
11.8.1 Allergan plc Corporation Information
11.8.2 Allergan plc Description and Business Overview
11.8.3 Allergan plc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Allergan plc Drug Allergy Treatments and Drugs Products Offered
11.8.5 Allergan plc Related Developments
11.9 Mayo Clinic
11.9.1 Mayo Clinic Corporation Information
11.9.2 Mayo Clinic Description and Business Overview
11.9.3 Mayo Clinic Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Mayo Clinic Drug Allergy Treatments and Drugs Products Offered
11.9.5 Mayo Clinic Related Developments
11.10 AAFA
11.10.1 AAFA Corporation Information
11.10.2 AAFA Description and Business Overview
11.10.3 AAFA Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AAFA Drug Allergy Treatments and Drugs Products Offered
11.10.5 AAFA Related Developments
11.1 Stallergenes Greer
11.1.1 Stallergenes Greer Corporation Information
11.1.2 Stallergenes Greer Description and Business Overview
11.1.3 Stallergenes Greer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Stallergenes Greer Drug Allergy Treatments and Drugs Products Offered
11.1.5 Stallergenes Greer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Drug Allergy Treatments and Drugs Market Estimates and Projections by Region
12.1.1 Global Drug Allergy Treatments and Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Drug Allergy Treatments and Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Drug Allergy Treatments and Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Drug Allergy Treatments and Drugs Sales Forecast (2021-2026)
12.2.2 North America: Drug Allergy Treatments and Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Drug Allergy Treatments and Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Drug Allergy Treatments and Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Drug Allergy Treatments and Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Drug Allergy Treatments and Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Drug Allergy Treatments and Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Drug Allergy Treatments and Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Drug Allergy Treatments and Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Drug Allergy Treatments and Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Drug Allergy Treatments and Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Drug Allergy Treatments and Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Drug Allergy Treatments and Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Drug Allergy Treatments and Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Drug Allergy Treatments and Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Drug Allergy Treatments and Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Drug Allergy Treatments and Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Drug Allergy Treatments and Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Drug Allergy Treatments and Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Drug Allergy Treatments and Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug Allergy Treatments and Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Drug Allergy Treatments and Drugs Market Segments
Table 2. Ranking of Global Top Drug Allergy Treatments and Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drug Allergy Treatments and Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Penicillin and Related Drugs
Table 5. Major Manufacturers of Sulfa Drugs
Table 6. Major Manufacturers of Insulin
Table 7. Major Manufacturers of Iodine
Table 8. Major Manufacturers of Chemotherapy Drugs
Table 9. Major Manufacturers of Other
Table 10. Global Drug Allergy Treatments and Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Drug Allergy Treatments and Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Drug Allergy Treatments and Drugs Sales by Regions 2015-2020 (K Units)
Table 13. Global Drug Allergy Treatments and Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Drug Allergy Treatments and Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Drug Allergy Treatments and Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Drug Allergy Treatments and Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Drug Allergy Treatments and Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Drug Allergy Treatments and Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Allergy Treatments and Drugs as of 2019)
Table 19. Drug Allergy Treatments and Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Drug Allergy Treatments and Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Drug Allergy Treatments and Drugs Price (2015-2020) (USD/Unit)
Table 22. Drug Allergy Treatments and Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Drug Allergy Treatments and Drugs Product Type
Table 24. Date of International Manufacturers Enter into Drug Allergy Treatments and Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Allergy Treatments and Drugs Sales by Type (2015-2020) (K Units)
Table 27. Global Drug Allergy Treatments and Drugs Sales Share by Type (2015-2020)
Table 28. Global Drug Allergy Treatments and Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Drug Allergy Treatments and Drugs Revenue Share by Type (2015-2020)
Table 30. Drug Allergy Treatments and Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Drug Allergy Treatments and Drugs Sales by Application (2015-2020) (K Units)
Table 32. Global Drug Allergy Treatments and Drugs Sales Share by Application (2015-2020)
Table 33. North America Drug Allergy Treatments and Drugs Sales by Country (2015-2020) (K Units)
Table 34. North America Drug Allergy Treatments and Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Drug Allergy Treatments and Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Drug Allergy Treatments and Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Drug Allergy Treatments and Drugs Sales by Type (2015-2020) (K Units)
Table 38. North America Drug Allergy Treatments and Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Drug Allergy Treatments and Drugs Sales by Application (2015-2020) (K Units)
Table 40. North America Drug Allergy Treatments and Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Drug Allergy Treatments and Drugs Sales by Country (2015-2020) (K Units)
Table 42. Europe Drug Allergy Treatments and Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Drug Allergy Treatments and Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Drug Allergy Treatments and Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Drug Allergy Treatments and Drugs Sales by Type (2015-2020) (K Units)
Table 46. Europe Drug Allergy Treatments and Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Drug Allergy Treatments and Drugs Sales by Application (2015-2020) (K Units)
Table 48. Europe Drug Allergy Treatments and Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Drug Allergy Treatments and Drugs Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Drug Allergy Treatments and Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Drug Allergy Treatments and Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Drug Allergy Treatments and Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Drug Allergy Treatments and Drugs Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Drug Allergy Treatments and Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Drug Allergy Treatments and Drugs Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Drug Allergy Treatments and Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Drug Allergy Treatments and Drugs Sales by Country (2015-2020) (K Units)
Table 58. Latin America Drug Allergy Treatments and Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Drug Allergy Treatments and Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Drug Allergy Treatments and Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Drug Allergy Treatments and Drugs Sales by Type (2015-2020) (K Units)
Table 62. Latin America Drug Allergy Treatments and Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Drug Allergy Treatments and Drugs Sales by Application (2015-2020) (K Units)
Table 64. Latin America Drug Allergy Treatments and Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Drug Allergy Treatments and Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Drug Allergy Treatments and Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Drug Allergy Treatments and Drugs Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share by Application (2015-2020)
Table 73. Stallergenes Greer Corporation Information
Table 74. Stallergenes Greer Description and Major Businesses
Table 75. Stallergenes Greer Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Stallergenes Greer Product
Table 77. Stallergenes Greer Recent Development
Table 78. Allergy Therapeutics Corporation Information
Table 79. Allergy Therapeutics Description and Major Businesses
Table 80. Allergy Therapeutics Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Allergy Therapeutics Product
Table 82. Allergy Therapeutics Recent Development
Table 83. HAL Allergy Group Corporation Information
Table 84. HAL Allergy Group Description and Major Businesses
Table 85. HAL Allergy Group Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. HAL Allergy Group Product
Table 87. HAL Allergy Group Recent Development
Table 88. Circassia Corporation Information
Table 89. Circassia Description and Major Businesses
Table 90. Circassia Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Circassia Product
Table 92. Circassia Recent Development
Table 93. GlaxoSmithKline plc Corporation Information
Table 94. GlaxoSmithKline plc Description and Major Businesses
Table 95. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. GlaxoSmithKline plc Product
Table 97. GlaxoSmithKline plc Recent Development
Table 98. Sunovion Pharmaceuticals Corporation Information
Table 99. Sunovion Pharmaceuticals Description and Major Businesses
Table 100. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Sunovion Pharmaceuticals Product
Table 102. Sunovion Pharmaceuticals Recent Development
Table 103. Teva Pharmaceutical Industries Corporation Information
Table 104. Teva Pharmaceutical Industries Description and Major Businesses
Table 105. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Teva Pharmaceutical Industries Product
Table 107. Teva Pharmaceutical Industries Recent Development
Table 108. Allergan plc Corporation Information
Table 109. Allergan plc Description and Major Businesses
Table 110. Allergan plc Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Allergan plc Product
Table 112. Allergan plc Recent Development
Table 113. Mayo Clinic Corporation Information
Table 114. Mayo Clinic Description and Major Businesses
Table 115. Mayo Clinic Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Mayo Clinic Product
Table 117. Mayo Clinic Recent Development
Table 118. AAFA Corporation Information
Table 119. AAFA Description and Major Businesses
Table 120. AAFA Drug Allergy Treatments and Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. AAFA Product
Table 122. AAFA Recent Development
Table 123. Global Drug Allergy Treatments and Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 124. Global Drug Allergy Treatments and Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Drug Allergy Treatments and Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Drug Allergy Treatments and Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Drug Allergy Treatments and Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 128. North America: Drug Allergy Treatments and Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Drug Allergy Treatments and Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. Europe: Drug Allergy Treatments and Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Drug Allergy Treatments and Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 132. Asia Pacific: Drug Allergy Treatments and Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Drug Allergy Treatments and Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 134. Latin America: Drug Allergy Treatments and Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Drug Allergy Treatments and Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 136. Middle East and Africa: Drug Allergy Treatments and Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Drug Allergy Treatments and Drugs Players
Table 141. Drug Allergy Treatments and Drugs Customers List
Table 142. Drug Allergy Treatments and Drugs Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Allergy Treatments and Drugs Product Picture
Figure 2. Global Drug Allergy Treatments and Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Penicillin and Related Drugs Product Picture
Figure 4. Sulfa Drugs Product Picture
Figure 5. Insulin Product Picture
Figure 6. Iodine Product Picture
Figure 7. Chemotherapy Drugs Product Picture
Figure 8. Other Product Picture
Figure 9. Global Drug Allergy Treatments and Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Hospitals
Figure 11. Diagnostic Laboratories
Figure 12. Research & Academic Laboratories
Figure 13. Pharmaceutical & Biotechnology Companies
Figure 14. Drug Allergy Treatments and Drugs Report Years Considered
Figure 15. Global Drug Allergy Treatments and Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Drug Allergy Treatments and Drugs Sales 2015-2026 (K Units)
Figure 17. Global Drug Allergy Treatments and Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Drug Allergy Treatments and Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Drug Allergy Treatments and Drugs Sales Market Share by Region in 2019
Figure 20. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region in 2019
Figure 22. Global Drug Allergy Treatments and Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Drug Allergy Treatments and Drugs Revenue in 2019
Figure 24. Drug Allergy Treatments and Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Drug Allergy Treatments and Drugs Sales Market Share by Type in 2019
Figure 27. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type in 2019
Figure 29. Global Drug Allergy Treatments and Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Drug Allergy Treatments and Drugs Sales Market Share by Application in 2019
Figure 32. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application in 2019
Figure 34. North America Drug Allergy Treatments and Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Drug Allergy Treatments and Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Drug Allergy Treatments and Drugs Sales Market Share by Country in 2019
Figure 37. North America Drug Allergy Treatments and Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Drug Allergy Treatments and Drugs Market Share by Type in 2019
Figure 43. North America Drug Allergy Treatments and Drugs Market Share by Application in 2019
Figure 44. Europe Drug Allergy Treatments and Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Drug Allergy Treatments and Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Drug Allergy Treatments and Drugs Sales Market Share by Country in 2019
Figure 47. Europe Drug Allergy Treatments and Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Drug Allergy Treatments and Drugs Market Share by Type in 2019
Figure 59. Europe Drug Allergy Treatments and Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Drug Allergy Treatments and Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Drug Allergy Treatments and Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Drug Allergy Treatments and Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Drug Allergy Treatments and Drugs Revenue Market Share by Region in 2019
Figure 64. China Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Drug Allergy Treatments and Drugs Market Share by Type in 2019
Figure 87. Asia Pacific Drug Allergy Treatments and Drugs Market Share by Application in 2019
Figure 88. Latin America Drug Allergy Treatments and Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Drug Allergy Treatments and Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Drug Allergy Treatments and Drugs Sales Market Share by Country in 2019
Figure 91. Latin America Drug Allergy Treatments and Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Drug Allergy Treatments and Drugs Market Share by Type in 2019
Figure 99. Latin America Drug Allergy Treatments and Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa Drug Allergy Treatments and Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Drug Allergy Treatments and Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Drug Allergy Treatments and Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Drug Allergy Treatments and Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Drug Allergy Treatments and Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Drug Allergy Treatments and Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Drug Allergy Treatments and Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa Drug Allergy Treatments and Drugs Market Share by Application in 2019
Figure 112. North America Drug Allergy Treatments and Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Drug Allergy Treatments and Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Drug Allergy Treatments and Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Drug Allergy Treatments and Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Drug Allergy Treatments and Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Drug Allergy Treatments and Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Drug Allergy Treatments and Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Drug Allergy Treatments and Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Drug Allergy Treatments and Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Drug Allergy Treatments and Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed